Risk-Specific Follow-up for Endometrial Carcinoma Patients

By Shumsky A.G.   Brasher P.M.A.   Stuart G.C.E.   Nation J.G.  

Gynecologic Oncology, Vol. 65, Iss. 3, 1997-06 ,pp. : 379-382

Elsevier

Access to resources Recommend Favorite

MIB-1 in Endometrial Carcinoma: Prognostic Significance with 5-Year Follow-Up

By Geisler J.P.   Geisler H.E.   Miller G.A.   Wiemann M.C.   Zhou Z.   Crabtree W.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 432-436

Elsevier

Access to resources Recommend Favorite

Long-Term Follow-up of Gonadotrophin-Releasing Hormone Analog Treatment for Recurrent Endometrial Cancer

By Jeyarajah A.R.   Gallagher C.J.   Blake P.R.   Oram D.H.   Dowsett M.   Fisher C.   Oliver R.T.D.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 47-52

Academic Press

Access to resources Recommend Favorite

Endometrial carcinoma: better prognosis for asymptomatic recurrences than for symptomatic cases found by routine follow-up

By Ueda Yutaka   Enomoto Takayuki   Egawa-Takata Tomomi   Miyatake Takashi   Yoshino Kiyoshi   Fujita Masami   Matsuzaki Shinya   Yokoyama Takuhei   Miyoshi Yukari   Kimura Tadashi  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 406-412

Springer Publishing Company

Access to resources Recommend Favorite

Cisplatin/5-Fluorouracil Treatment of Recurrent Cervical Carcinoma: A Phase II Study with Long-Term Follow-up

By Kaern J.   Trope C.   Sundfoer K.   Kristensen G.B.  

Gynecologic Oncology, Vol. 60, Iss. 3, 1996-03 ,pp. : 387-392

Academic Press

Access to resources Recommend Favorite